Drug profile · INN
cidofovir
VISTIDE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
cidofovir (VISTIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN cidofovir
Brand VISTIDE
Route INTRAVENOUS
Formulation SOLUTION
ATC code J05AB12
Frequently asked questions
What is cidofovir?
cidofovir (VISTIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for cidofovir?
VISTIDE is a marketed brand name for cidofovir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cidofovir?
cidofovir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.